CLINICAL_TRIALS
trial_result
· 2021-01-13
Clinical Trial Update: Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors [Phase 2]
Summary
Phase 2 clinical trial evaluating tamoxifen for low/intermediate risk bladder tumors has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor College of Medicine | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-01-13